AstraZeneca and Vodafone enter partnership to improve cardiovascular health

By Admin
Share
The recent announcement of a global partnership between Vodafone and the UK’s AstraZeneca is bent on assisting patients with serious cardiova...

The recent announcement of a global partnership between Vodafone and the UK’s AstraZeneca is bent on assisting patients with serious cardiovascular conditions. This relationship will work with various healthcare professionals using mobile technology to increase patient communication capabilities: both mHealth and internet-based mHealth services.

Taking lead on the project, AstraZeneca’s Intelligent Pharmaceutical Group will spearhead the project’s management and development components, with Vodafone’s technology, infrastructure and expertise as the backbone behind its ideas.

Vodafone’s Director for its Machine to Machine program stated, “Bringing together the best in connectivity with the best in treatment and education will create powerful and compelling outcomes for patients. AstraZeneca is a global leader in the mHealth field and we are delighted to work with them to develop these innovative services.”

Share

Featured Articles

Schneider Electric Powers Healthcare Facilities with Solar

Schneider Electric’s solar solutions are bringing healthcare to millions across Africa and India, as the company seeks to revolutionise rural healthcare

Apollo Hospitals’ Q2 Net Profit Soars by 63%

After a successful partnership with Monash & standing in solidarity with female healthcare staff, Apollo Hospitals’ Q2 performance surpasses forecasts

The Future of Cell Therapy for Thermo Fisher & Novo Nordisk

Thermo Fisher & Novo Nordisk Foundation Cellerator partner to advance cell manufacturing at innovation hub, to help patients with chronic health conditions

TikTok's Role in Healthcare: Safeguarding to Misinformation

Technology & AI

CareYaya’s MedaCareLLM AI Glasses Support Dementia Patients

Technology & AI

McKinsey: How AI is Addressing the Mental Health Crisis

Technology & AI